{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:07:04Z","timestamp":1792782424148,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4t Bielefeld","id":[{"id":"https:\/\/ror.org\/02hpadn98","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Premature termination codons (PTCs) in the\n                    <jats:italic>MECP2<\/jats:italic>\n                    gene are a major cause of Rett syndrome, resulting in truncated proteins and loss of function. Pharmacological induction of translational readthrough (TR) can restore full-length protein, but clinical translation is hindered by the limited efficiency and toxicity of current inducers. Here, we investigated whether targeted degradation of the eukaryotic Release Factor 3a by the small molecules CC-885 or CC-90009 enhances TR at\n                    <jats:italic>MECP2<\/jats:italic>\n                    PTCs in HeLa cells. Using a dual-fluorescence reporter assay, we found that neither degrader alone significantly increased TR efficiency. However, cotreatment with the TR inducer G418 produced a synergistic effect, resulting in increased TR compared to G418 alone. Although gentamicin, a less toxic TR inducer, led to only weak TR induction on its own, combination with CC-885 resulted in TR levels similar to G418. Combined CC-885 and G418 treatment enabled recovery of full-length MeCP2 protein as well as proper nuclear localization, consistent with functional recovery of the nuclear localization signal. These findings establish eRF3a degradation as a potential strategy to enhance TR and suggest that the combination of aminoglycosides with release factor degraders could provide a less toxic yet effective therapeutic option for PTC-associated disorders.\n                  <\/jats:p>","DOI":"10.1007\/s00109-026-02728-z","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:14:02Z","timestamp":1792631642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Release factor 3 degradation enhances aminoglycoside-mediated translational readthrough at MECP2 nonsense mutations"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3535-2163","authenticated-orcid":false,"given":"Dennis","family":"Lebeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6388-3205","authenticated-orcid":false,"given":"Daniela","family":"Smoljanow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2774-1661","authenticated-orcid":false,"given":"Julia","family":"Hofhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3018-6363","authenticated-orcid":false,"given":"Sven","family":"Thoms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"2728_CR1","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ana.22124","volume":"68","author":"JL Neul","year":"2010","unstructured":"Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, Leonard H, Bailey MES, Schanen NC, Zappella M, Renieri A, Huppke P, Percy AK (2010) Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 68:944\u2013950","journal-title":"Ann Neurol"},{"key":"2728_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrg3897","volume":"16","author":"MJ Lyst","year":"2015","unstructured":"Lyst MJ, Bird A (2015) Rett syndrome: a complex disorder with simple roots. Nat Rev Genet 16:261\u2013275","journal-title":"Nat Rev Genet"},{"key":"2728_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/MCB.16.1.414","volume":"16","author":"X Nan","year":"1996","unstructured":"Nan X, Tate P, Li E, Bird A (1996) DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol 16:414\u2013421","journal-title":"Mol Cell Biol"},{"key":"2728_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature14319","volume":"522","author":"HW Gabel","year":"2015","unstructured":"Gabel HW, Kinde B, Stroud H, Gilbert CS, Harmin DA, Kastan NR, Hemberg M, Ebert DH, Greenberg ME (2015) Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Nature 522:89\u201393","journal-title":"Nature"},{"key":"2728_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24044218","volume":"24","author":"YM Vuu","year":"2023","unstructured":"Vuu YM, Roberts C-T, Rastegar M (2023) MeCP2 is an epigenetic factor that links DNA methylation with brain metabolism. Int J Mol Sci 24:4218","journal-title":"Int J Mol Sci"},{"key":"2728_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ng1327","volume":"36","author":"GN Mnatzakanian","year":"2004","unstructured":"Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, MacLeod PJM, Jones JR, Scherer SW, Schanen NC, Friez MJ, Vincent JB, Minassian BA (2004) A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 36:339\u2013341","journal-title":"Nat Genet"},{"key":"2728_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00109-024-02436-6","volume":"102","author":"D Lebeda","year":"2024","unstructured":"Lebeda D, Fierenz A, Werfel L, Rosin-Arbesfeld R, Hofhuis J, Thoms S (2024) Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations. J Mol Med (Berl) 102:641\u2013653","journal-title":"J Mol Med (Berl)"},{"key":"2728_CR8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrm3454","volume":"13","author":"S Kervestin","year":"2012","unstructured":"Kervestin S, Jacobson A (2012) NMD: a multifaceted response to premature translational termination. Nat Rev Mol Cell Biol 13:700\u2013712","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2728_CR9","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.03640","volume":"3","author":"F Schueren","year":"2014","unstructured":"Schueren F, Lingner T, George R, Hofhuis J, Dickel C, G\u00e4rtner J, Thoms S (2014) Peroxisomal lactate dehydrogenase is generated by translational readthrough in mammals. Elife 3:e03640","journal-title":"Elife"},{"key":"2728_CR10","doi-asserted-by":"publisher","unstructured":"Hofhuis J, Schueren F, N\u00f6tzel C, Lingner T, G\u00e4rtner J, Jahn O, Thoms S (2016) The functional readthrough extension of malate dehydrogenase reveals a modification of the genetic code. Open Biol 6:. https:\/\/doi.org\/10.1098\/rsob.160246","DOI":"10.1098\/rsob.160246"},{"issue":"11","key":"2728_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006196","volume":"12","author":"F Schueren","year":"2016","unstructured":"Schueren F, Thoms S (2016) Functional translational readthrough: a systems biology perspective. PLoS Genet 12(11):e1006196","journal-title":"PLoS Genet"},{"key":"2728_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/wrna.95","volume":"2","author":"KM Keeling","year":"2011","unstructured":"Keeling KM, Bedwell DM (2011) Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases. Wiley Interdiscip Rev RNA 2:837\u2013852","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"2728_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-03809-7","author":"P Martins-Dias","year":"2021","unstructured":"Martins-Dias P, Rom\u00e3o L (2021) Nonsense suppression therapies in human genetic diseases. Cell Mol Life Sci. https:\/\/doi.org\/10.1007\/s00018-021-03809-7","journal-title":"Cell Mol Life Sci"},{"key":"2728_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s10020-018-0024-7","volume":"24","author":"M Dabrowski","year":"2018","unstructured":"Dabrowski M, Bukowy-Bieryllo Z, Zietkiewicz E (2018) Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons. Mol Med Camb Mass 24:25","journal-title":"Mol Med Camb Mass"},{"issue":"22","key":"2728_CR15","first-page":"01392","volume":"S1569\u20131993","author":"IM Pranke","year":"2022","unstructured":"Pranke IM, Varilh J, Hatton A, Faucon C, Girodon E, Dreano E, Chevalier B, Karri S, Reix P, Durieu I, Bidou L, Namy O, Taulan M, Hinzpeter A, Sermet-Gaudelus I (2022) The U UGA C sequence provides a favorable context to ELX-02 induced CFTR readthrough. J Cyst Fibros Off J Eur Cyst Fibros Soc S1569\u20131993(22):01392\u201301393","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"2728_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004685","volume":"10","author":"AC Stiebler","year":"2014","unstructured":"Stiebler AC, Freitag J, Schink KO, Stehlik T, Tillmann BAM, Ast J, B\u00f6lker M (2014) Ribosomal readthrough at a short UGA stop codon context triggers dual localization of metabolic enzymes in fungi and animals. PLoS Genet 10:e1004685","journal-title":"PLoS Genet"},{"key":"2728_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1011753","volume":"21","author":"D Smoljanow","year":"2025","unstructured":"Smoljanow D, Lebeda D, Hofhuis J, Thoms S (2025) Defining the high-translational readthrough stop codon context. PLoS Genet 21:e1011753","journal-title":"PLoS Genet"},{"key":"2728_CR18","doi-asserted-by":"publisher","first-page":"E10899","DOI":"10.1073\/pnas.1715501114","volume":"114","author":"I Prokhorova","year":"2017","unstructured":"Prokhorova I, Altman RB, Djumagulov M, Shrestha JP, Urzhumtsev A, Ferguson A, Chang C-WT, Yusupov M, Blanchard SC, Yusupova G (2017) Aminoglycoside interactions and impacts on the eukaryotic ribosome. Proc Natl Acad Sci U S A 114:E10899\u2013E10908","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2728_CR19","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/hmg\/ddp030","volume":"18","author":"CR Heier","year":"2009","unstructured":"Heier CR, DiDonato CJ (2009) Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo. Hum Mol Genet 18:1310\u20131322","journal-title":"Hum Mol Genet"},{"key":"2728_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/biom11071006","volume":"11","author":"M Schilff","year":"2021","unstructured":"Schilff M, Sargsyan Y, Hofhuis J, Thoms S (2021) Stop codon context-specific induction of translational readthrough. Biomolecules 11:1006","journal-title":"Biomolecules"},{"key":"2728_CR21","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1093\/hmg\/ddaa102","volume":"29","author":"JK Merritt","year":"2020","unstructured":"Merritt JK, Collins BE, Erickson KR, Dong H, Neul JL (2020) Pharmacological read-through of R294X Mecp2 in a novel mouse model of Rett syndrome. Hum Mol Genet 29:2461\u20132470","journal-title":"Hum Mol Genet"},{"key":"2728_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","volume":"89","author":"C Brendel","year":"2011","unstructured":"Brendel C, Belakhov V, Werner H, Wegener E, G\u00e4rtner J, Nudelman I, Baasov T, Huppke P (2011) Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model. J Mol Med Berl Ger 89:389\u2013398","journal-title":"J Mol Med Berl Ger"},{"key":"2728_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1203\/PDR.0b013e31819d9ebc","volume":"65","author":"C Brendel","year":"2009","unstructured":"Brendel C, Klahold E, G\u00e4rtner J, Huppke P (2009) Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics. Pediatr Res 65:520\u2013523","journal-title":"Pediatr Res"},{"key":"2728_CR24","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/jnr.22409","volume":"88","author":"AC Popescu","year":"2010","unstructured":"Popescu AC, Sidorova E, Zhang G, Eubanks JH (2010) Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro. J Neurosci Res 88:2316\u20132324","journal-title":"J Neurosci Res"},{"key":"2728_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020733","volume":"6","author":"M Vecsler","year":"2011","unstructured":"Vecsler M, Ben Zeev B, Nudelman I, Anikster Y, Simon AJ, Amariglio N, Rechavi G, Baasov T, Gak E (2011) Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations. PLoS ONE 6:e20733","journal-title":"PLoS ONE"},{"key":"2728_CR26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature18611","volume":"535","author":"ME Matyskiela","year":"2016","unstructured":"Matyskiela ME, Lu G, Ito T, Pagarigan B, Lu C-C, Miller K, Fang W, Wang N-Y, Nguyen D, Houston J, Carmel G, Tran T, Riley M, Nosaka L, Lander GC, Gaidarova S, Xu S, Ruchelman AL, Handa H, Carmichael J, Daniel TO, Cathers BE, Lopez-Girona A, Chamberlain PP (2016) A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase. Nature 535:252\u2013257","journal-title":"Nature"},{"key":"2728_CR27","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1093\/nar\/gkab194","volume":"49","author":"A Baradaran-Heravi","year":"2021","unstructured":"Baradaran-Heravi A, Balgi AD, Hosseini-Farahabadi S, Choi K, Has C, Roberge M (2021) Effect of small molecule eRF3 degraders on premature termination codon readthrough. Nucleic Acids Res 49:3692\u20133708","journal-title":"Nucleic Acids Res"},{"key":"2728_CR28","doi-asserted-by":"publisher","first-page":"L756","DOI":"10.1152\/ajplung.00038.2023","volume":"324","author":"J Chen","year":"2023","unstructured":"Chen J, Thrasher K, Fu L, Wang W, Aghamohammadzadeh S, Wen H, Tang L, Keeling KM, Falk Libby E, Bedwell DM, Rowe SM (2023) The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulators. Am J Physiol Lung Cell Mol Physiol 324:L756\u2013L770","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2728_CR29","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41589-023-01521-0","volume":"20","author":"JP Coelho","year":"2024","unstructured":"Coelho JP, Yip MC, Oltion K, Taunton J, Shao S (2024) The eRF1 degrader SRI-41315 acts as a molecular glue at the ribosomal decoding center. Nat Chem Biol 20:877\u2013884","journal-title":"Nat Chem Biol"},{"key":"2728_CR30","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1016\/j.febslet.2007.05.082","volume":"581","author":"R Wang","year":"2007","unstructured":"Wang R, Brattain MG (2007) The maximal size of protein to diffuse through the nuclear pore is larger than 60kDa. FEBS Lett 581:3164\u20133170","journal-title":"FEBS Lett"},{"key":"2728_CR31","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.bpj.2009.06.024","volume":"97","author":"S Shimozono","year":"2009","unstructured":"Shimozono S, Tsutsui H, Miyawaki A (2009) Diffusion of large molecules into assembling nuclei revealed using an optical highlighting technique. Biophys J 97:1288\u20131294","journal-title":"Biophys J"},{"key":"2728_CR32","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1101\/gad.1770109","volume":"23","author":"Z Cheng","year":"2009","unstructured":"Cheng Z, Saito K, Pisarev AV, Wada M, Pisareva VP, Pestova TV, Gajda M, Round A, Kong C, Lim M, Nakamura Y, Svergun DI, Ito K, Song H (2009) Structural insights into eRF3 and stop codon recognition by eRF1. Genes Dev 23:1106\u20131118","journal-title":"Genes Dev"},{"key":"2728_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117642","volume":"291","author":"S Park","year":"2025","unstructured":"Park S, Takwale AD, Lee J-E, Yu N, Kim YH, Lee JY, Cho YH, Cho JH, Moon JH, Lee G, Kim J-A, Hwang JY, Kim J-H (2025) Discovery of a novel molecular glue degrader targeting GSPT1\/2 with a non-IMiD-based CRBN binder. Eur J Med Chem 291:117642","journal-title":"Eur J Med Chem"},{"key":"2728_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1080\/15476286.2023.2222250","volume":"20","author":"A Heldin","year":"2023","unstructured":"Heldin A, Cancer M, Palomar-Siles M, \u00d6hlin S, Zhang M, Sun-Zhang A, Mariani A, Liu J, Bykov VJN, Wiman KG (2023) Novel compounds that synergize with aminoglycoside G418 or eRF3 degraders for translational readthrough of nonsense mutant TP53 and PTEN. RNA Biol 20:368\u2013383","journal-title":"RNA Biol"},{"key":"2728_CR35","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1038\/s41467-024-46703-z","volume":"15","author":"K Mangkalaphiban","year":"2024","unstructured":"Mangkalaphiban K, Fu L, Du M, Thrasher K, Keeling KM, Bedwell DM, Jacobson A (2024) Extended stop codon context predicts nonsense codon readthrough efficiency in human cells. Nat Commun 15:2486","journal-title":"Nat Commun"},{"key":"2728_CR36","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52611","volume":"9","author":"JR Wangen","year":"2020","unstructured":"Wangen JR, Green R (2020) Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides. Elife 9:e52611","journal-title":"Elife"},{"key":"2728_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002608","volume":"8","author":"C Floquet","year":"2012","unstructured":"Floquet C, Hatin I, Rousset J-P, Bidou L (2012) Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin. PLoS Genet 8:e1002608","journal-title":"PLoS Genet"},{"key":"2728_CR38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1001\/jamadermatol.2022.0112","volume":"158","author":"L Mart\u00ednez-Santamar\u00eda","year":"2022","unstructured":"Mart\u00ednez-Santamar\u00eda L, Maseda R, de Arriba MDC, Membrilla JA, Sig\u00fcenza AI, Masc\u00edas J, Garc\u00eda M, Quintana L, Esteban-Rodr\u00edguez I, Hern\u00e1ndez-Fern\u00e1ndez CP, Illera N, Duarte B, Guerrero-Aspiz\u00faa S, Woodley DT, Del R\u00edo M, de Lucas R, Larcher F, Esc\u00e1mez MJ (2022) Evaluation of systemic gentamicin as translational readthrough therapy for a patient with epidermolysis bullosa simplex with muscular dystrophy owing to PLEC1 pathogenic nonsense variants. JAMA Dermatol 158:439\u2013443","journal-title":"JAMA Dermatol"},{"key":"2728_CR39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1001\/jamadermatol.2021.5992","volume":"158","author":"D Mosallaei","year":"2022","unstructured":"Mosallaei D, Hao M, Antaya RJ, Levian B, Kwong A, Cogan J, Hamilton C, Schwieger-Briel A, Tan C, Tang X, Woodley DT, Chen M (2022) Molecular and clinical outcomes after intravenous gentamicin treatment for patients with junctional epidermolysis bullosa caused by nonsense variants. JAMA Dermatol 158:366\u2013374","journal-title":"JAMA Dermatol"},{"key":"2728_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/biom13060988","volume":"13","author":"S Li","year":"2023","unstructured":"Li S, Li J, Shi W, Nie Z, Zhang S, Ma F, Hu J, Chen J, Li P, Xie X (2023) Pharmaceuticals promoting premature termination codon readthrough: progress in development. Biomolecules 13:988","journal-title":"Biomolecules"},{"key":"2728_CR41","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1128\/MCB.00035-07","volume":"27","author":"C Chauvin","year":"2007","unstructured":"Chauvin C, Salhi S, Jean-Jean O (2007) Human eukaryotic release factor 3a depletion causes cell cycle arrest at G1 phase through inhibition of the mTOR pathway. Mol Cell Biol 27:5619\u20135629","journal-title":"Mol Cell Biol"},{"key":"2728_CR42","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","volume":"139","author":"PD Stenson","year":"2020","unstructured":"Stenson PD, Mort M, Ball EV, Chapman M, Evans K, Azevedo L, Hayden M, Heywood S, Millar DS, Phillips AD, Cooper DN (2020) The Human Gene Mutation Database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting. Hum Genet 139:1197\u20131207","journal-title":"Hum Genet"},{"key":"2728_CR43","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/s41467-022-30080-6","volume":"13","author":"S Huang","year":"2022","unstructured":"Huang S, Bhattacharya A, Ghelfi MD, Li H, Fritsch C, Chenoweth DM, Goldman YE, Cooperman BS (2022) Ataluren binds to multiple protein synthesis apparatus sites and competitively inhibits release factor-dependent termination. Nat Commun 13:2413","journal-title":"Nat Commun"},{"key":"2728_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf216","volume":"53","author":"SY Bhat","year":"2025","unstructured":"Bhat SY, Bhattacharya A, Li H, Cui X, Lueck JD, Goldman YE, Cooperman BS (2025) Mechanism-based approach in designing patient-specific combination therapies for nonsense mutation diseases. Nucleic Acids Res 53:gkaf216","journal-title":"Nucleic Acids Res"},{"key":"2728_CR45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2020599118","volume":"118","author":"MY Ng","year":"2021","unstructured":"Ng MY, Li H, Ghelfi MD, Goldman YE, Cooperman BS (2021) Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms. Proc Natl Acad Sci U S A 118:e2020599118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2728_CR46","doi-asserted-by":"publisher","first-page":"10061","DOI":"10.1093\/nar\/gku663","volume":"42","author":"S Blanchet","year":"2014","unstructured":"Blanchet S, Cornu D, Argentini M, Namy O (2014) New insights into the incorporation of natural suppressor tRNAs at stop codons in Saccharomyces cerevisiae. Nucleic Acids Res 42:10061\u201310072","journal-title":"Nucleic Acids Res"},{"key":"2728_CR47","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.xphs.2024.02.006","volume":"113","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Khanal N, Dykstra AB, Daris K (2024) Stop-codon readthrough in therapeutic protein candidates expressed from mammalian cells. J Pharm Sci 113:1498\u20131505","journal-title":"J Pharm Sci"},{"key":"2728_CR48","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000315906","volume":"129","author":"LA Kifayathullah","year":"2010","unstructured":"Kifayathullah LA, Arunachalam JP, Bodda C, Agbemenyah HY, Laccone FA, Mannan AU (2010) MeCP2270 mutant protein is expressed in astrocytes as well as in neurons and localizes in the nucleus. Cytogenet Genome Res 129:290\u2013297","journal-title":"Cytogenet Genome Res"},{"key":"2728_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4939-6937-1_9","volume-title":"Peroxisomes: methods and protocols","author":"J Hofhuis","year":"2017","unstructured":"Hofhuis J, Dieterle S, George R, Schueren F, Thoms S (2017) Dual reporter systems for the analysis of translational readthrough in mammals. In: Schrader M (ed) Peroxisomes: methods and protocols. Springer, New York, NY, pp 81\u201392"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02728-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:14:03Z","timestamp":1792631643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02728-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2728"],"URL":"https:\/\/doi.org\/10.1007\/s00109-026-02728-z","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"4 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicalble.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"123"}}